Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Chung

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Antimicrobial Agents|August 26, 2023
Association between vancomycin therapeutic drug monitoring and clinical outcomes in treating neonatal sepsisErin Chung, Winnie Seto
Pharmacotherapy|August 14, 2023
Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase-negative staphylococcusErin Chung, Winnie Seto
Journal of Hospital Medicine|October 27, 2025
Clinical progress note: Invasive meningococcal diseaseAlaina Shine, Erin Chung
Reviews in Medical Virology|March 8, 2012
The ongoing pursuit of a prophylactic HSV vaccineErin Chung, Jonathan Sen
Heart, Lung & Circulation|April 1, 2018
Tolvaptan for Heart Failure in Chronic Kidney Disease Patients: A Systematic Review and Meta-AnalysisJonathan Sen, Erin Chung, Darryl McGill
BMJ Open|October 6, 2020
Antihypertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysisJonathan Sen, Erin Chung, Christopher Neil, et al.
Paediatrics & Child Health|March 3, 2023
Metabolic acidosis during continuous glucagon therapy for neonatal hypoglycemiaRebecca Hoban, Christopher Tomlinson, Erin Chung, et al.
Clinical Pharmacokinetics|May 18, 2021
Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic ReviewErin Chung, Jonathan Sen, Priya Patel, et al.
Children (Basel, Switzerland)|May 27, 2026
Vancomycin Therapeutic Drug Monitoring, Clinical Outcomes and Population Pharmacokinetic Model Evaluation in NeonatesErin Chung, Najla Tabbara, Winnie Seto, et al.
Canadian Journal of Physiology and Pharmacology|March 30, 2013
Modeling xenobiotic susceptibility to hepatotoxicity using an in vitro oxidative stress inflammation modelStephanie L MacAllister, Abdullah A Maruf, Luke Wan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Antimicrobial Agents|August 26, 2023
Association between vancomycin therapeutic drug monitoring and clinical outcomes in treating neonatal sepsisErin Chung, Winnie Seto
Pharmacotherapy|August 14, 2023
Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase-negative staphylococcusErin Chung, Winnie Seto
Journal of Hospital Medicine|October 27, 2025
Clinical progress note: Invasive meningococcal diseaseAlaina Shine, Erin Chung
Reviews in Medical Virology|March 8, 2012
The ongoing pursuit of a prophylactic HSV vaccineErin Chung, Jonathan Sen
Heart, Lung & Circulation|April 1, 2018
Tolvaptan for Heart Failure in Chronic Kidney Disease Patients: A Systematic Review and Meta-AnalysisJonathan Sen, Erin Chung, Darryl McGill
BMJ Open|October 6, 2020
Antihypertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysisJonathan Sen, Erin Chung, Christopher Neil, et al.
Paediatrics & Child Health|March 3, 2023
Metabolic acidosis during continuous glucagon therapy for neonatal hypoglycemiaRebecca Hoban, Christopher Tomlinson, Erin Chung, et al.
Clinical Pharmacokinetics|May 18, 2021
Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic ReviewErin Chung, Jonathan Sen, Priya Patel, et al.
Children (Basel, Switzerland)|May 27, 2026
Vancomycin Therapeutic Drug Monitoring, Clinical Outcomes and Population Pharmacokinetic Model Evaluation in NeonatesErin Chung, Najla Tabbara, Winnie Seto, et al.
Canadian Journal of Physiology and Pharmacology|March 30, 2013
Modeling xenobiotic susceptibility to hepatotoxicity using an in vitro oxidative stress inflammation modelStephanie L MacAllister, Abdullah A Maruf, Luke Wan, et al.
Pageof 3